SCHEMBL126322

SCHEMBL126322

CC(C)(c1ccc(OC(=O)c2ccccc2)cc1)c1ccc(OC(=O)c2ccccc2)cc1

nearest known ligand 0.81

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.81
TDP1 Q9NUW8 4/20 0.81
L3MBTL1 Q9Y468 1/20 0.81
KMT2A Q03164 9/20 0.60
ALDH1A1 P00352 4/20 0.60
PKM P14618 1/20 0.60
PARP10 Q53GL7 1/20 0.59
MEN1 O00255 3/20 0.57
THRB P10828 1/20 0.55
RAB9A P51151 1/20 0.53
ELANE P08246 3/20 0.51
PRSS1 P07477 1/20 0.50
ACR P10323 1/20 0.50
NPSR1 Q6W5P4 1/20 0.49
TSHR P16473 1/20 0.49
HSD17B10 Q99714 1/20 0.49
CASP3 P42574 1/20 0.48
SENP7 Q9BQF6 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1192185 0.98 MAPT (0.78) MAPTTDP1L3MBTL1KMT2AALDH1A1
SCHEMBL12337501 0.94 MAPT (0.71) MAPTTDP1L3MBTL1KMT2AALDH1A1
SCHEMBL13343243 0.94 MAPT (0.71) MAPTTDP1L3MBTL1KMT2AALDH1A1
SCHEMBL141568 0.94 MAPT (0.71) MAPTTDP1L3MBTL1KMT2AALDH1A1
SCHEMBL3424218 0.94 MAPT (0.71) MAPTTDP1L3MBTL1KMT2AALDH1A1
SCHEMBL14151751 0.92 MAPT (0.69) MAPTTDP1L3MBTL1KMT2AALDH1A1
SCHEMBL12451790 0.92 MAPT (0.69) MAPTTDP1L3MBTL1KMT2AALDH1A1
SCHEMBL26038985 0.92 MAPT (0.69) MAPTTDP1L3MBTL1KMT2AALDH1A1
SCHEMBL12451793 0.92 MAPT (0.69) MAPTTDP1L3MBTL1KMT2AALDH1A1
SCHEMBL20346185 0.92 MAPT (0.69) MAPTTDP1L3MBTL1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1068 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240254286-A1 POLYESTERIMIDE RESIN COMPOSITION, POLYESTERIMIDE RESIN LAYER, FLEXIBLE METAL FOIL LAMINATE, AND METHODS OF PREPARING THE SAME NEXFLEX CO., LTD. (KR) 2024-08-01 US claimed
US-12534574-B2 System and method for manufacturing polyamic acid, and system and method for manufacturing polyimide KANEKA CORPORATION (JP) 2026-01-27 US disclosed
WO-2025053071-A1 POROUS FILM AND METHOD FOR PRODUCING POROUS FILM 東京応化工業株式会社 2025-03-13 WO disclosed
US-12227609-B2 Thermosetting resin composition, thermosetting resin film, thermoset film, multilayer body, printed wiring board and method for producing same KANEKA CORPORATION (JP) 2025-02-18 US disclosed
US-20240392131-A1 RESIN COMPOSITION, MOLDED BODY, AND FILM KANEKA CORPORATION (JP) 2024-11-28 US disclosed
US-20240327573-A1 SYSTEM AND METHOD FOR MANUFACTURING POLYAMIC ACID, AND SYSTEM AND METHOD FOR MANUFACTURING POLYIMIDE KANEKA CORPORATION (JP) 2024-10-03 US disclosed
US-12054586-B2 System and method for manufacturing polyamic acid, and system and method for manufacturing polyimide KANEKA CORPORATION (JP) 2024-08-06 US disclosed
US-20240254286-A1 POLYESTERIMIDE RESIN COMPOSITION, POLYESTERIMIDE RESIN LAYER, FLEXIBLE METAL FOIL LAMINATE, AND METHODS OF PREPARING THE SAME NEXFLEX CO., LTD. (KR) 2024-08-01 US disclosed
US-12029108-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2024-07-02 US disclosed
EP-4329431-A2 NOVEL HETEROLEPTIC IRIDIUM COMPLEXES Universal Display Corporation (US) 2024-02-28 EP disclosed
US-20100072887-A1 ORGANOSELENIUM MATERIALS AND THEIR USES IN ORGANIC LIGHT EMITTING DEVICES UNIVERSAL DISPLAY CORPORATION 2010-03-25 US disclosed
US-20100072887-A1 ORGANOSELENIUM MATERIALS AND THEIR USES IN ORGANIC LIGHT EMITTING DEVICES UNIVERSAL DISPLAY CORPORATION 2010-03-25 US disclosed
EP-1819717-B1 USE OF TRANSITION METAL CARBENE COMPLEXES IN ORGANIC LIGHT-EMITTING DIODES (OLEDS) BASF SE (DE) 2009-07-08 EP disclosed
US-20090096367-A1 HETEROLEPTIC TRANSITION METAL-CARBENE COMPLEXES AND THEIR USE IN ORGANIC LIGHT-EMITTING DIODES (OLEDS) BASF SE (DE) 2009-04-16 US disclosed
US-20090096367-A1 HETEROLEPTIC TRANSITION METAL-CARBENE COMPLEXES AND THEIR USE IN ORGANIC LIGHT-EMITTING DIODES (OLEDS) BASF SE (DE) 2009-04-16 US disclosed
WO-2007115970-A1 HETEROLEPTIC TRANSITION METAL-CARBENE COMPLEXES AND THEIR USE IN ORGANIC LIGHT-EMITTING DIODES (OLEDS) BASF SE (DE) 2007-10-18 WO disclosed
US-20060115670-A1 Thermoplastic polyimide resin film, multilayer body and method for manufacturing printed wiring board composed of same KANEKA CORPORATION (JP) 2006-06-01 US disclosed
EP-0972776-B1 A phosphine sulfide, a manufacturing process therefor and a use thereof MITSUI CHEMICALS INC (JP) 2003-04-23 EP disclosed
US-6153794-A Phosphine sulfide, a manufacturing process therefor and use thereof MITSUI CHEMICALS, INC. (JP) 2000-11-28 US disclosed
EP-0972776-A1 A phosphine sulfide, a manufacturing process therefor and a use thereof Mitsui Chemicals, Inc. (JP) 2000-01-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12029108-B2 Organic electroluminescent materials and devices LBR, DBF4, DNMT3A MAPT 4748/4885TDP1 3188/4885L3MBTL1 229/4885
US-20090096367-A1 HETEROLEPTIC TRANSITION METAL-CARBENE COMPLEXES AND THEIR USE IN ORGANIC LIGHT-EMITTING DIODES (OLEDS) OCIAD2, OCIAD1, ICOSLG MAPT 699/4885TDP1 3849/4885L3MBTL1 385/4885
US-12534574-B2 System and method for manufacturing polyamic acid, and system and method for manufacturing polyimide PARG, FGB, PUF60 MAPT 1295/4885TDP1 3205/4885L3MBTL1 2246/4885
US-20100072887-A1 ORGANOSELENIUM MATERIALS AND THEIR USES IN ORGANIC LIGHT EMITTING DEVICES SCLY, BZW2, GPX4 MAPT 1113/4885TDP1 3502/4885L3MBTL1 843/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.